Yantai Rongchang Pharmaceutical Co., Ltd.

Yantai Rongchang Pharmaceutical Co., Ltd. was established on 1 March 1993 18, located at Rongchang Road1Yantai Economic and Technological Rongchang Pharmaceutical Development Zone, with a registered capital of 90 million yuan and more than 700 employees, including nearly 40 high-tech talents such as doctors and masters, and more than 20 middle and senior technical titles/kloc-0. Mainly engaged in the technology development and technology transfer of Chinese and western medicines, producing suppositories, ointments, hard capsules, oral liquids, navel patches and tablets. The sales network covers all provincial capitals except Tibet, Hong Kong, Macao and Taiwan, most prefecture-level cities and important county-level cities, and the products are sold to more than 10 countries and regions. Since its establishment, the company has been committed to the development and application of Chinese medicine modernization. The leading product "Anal Thai" is the crystallization of TCM modernization. On the basis of China's traditional medical theory, he introduced four high-tech technologies: concentration, transdermal drug delivery, sustained release and application, and pioneered the method of "treating hemorrhoids by applying navel" in the world, becoming a national confidential variety and a well-known brand of traditional Chinese medicine. Later, more than ten products such as Sweet Dream Series, Kunning Oral Liquid for the treatment of dysfunctional uterine bleeding, Yuetai Tieqiu Tablet for the treatment of primary dysmenorrhea, bisacodyl Suppository for constipation (Jietai) and Compound Famotidine Chewable Tablet for the treatment of stomach diseases were successively developed and produced, and five invention patents were obtained. Five products were listed as national traditional Chinese medicine protection varieties by the US Food and Drug Administration. Seven products have been listed in the national basic medical insurance and industrial injury drugs list, providing satisfactory services for consumers, occupying a considerable market share and achieving good social and economic benefits. In order to ensure the stability and consistency of product quality, the company has established a whole process quality assurance system covering supply, production, development and marketing, and safeguarded the rights and interests of consumers. It has been rated as "drug quality integrity unit" and "consumer satisfaction unit" for many times. Anal Thai series, one of the leading products, has been rated as "the brand with the highest recommendation rate by shop assistants" for five consecutive years because of its stable quality and exact curative effect. While developing the modernization of traditional Chinese medicine and making outstanding achievements, the company set foot in the field of bioengineering technology and became one of the most active enterprises on the biotechnology stage in China. 1June, 1999, the company cooperated with the American doctoral team to carry out bioengineering research, and in 2005, it successfully developed a new class of biological anti-tumor drugs-recombinant human endostatin "YH- 16" (trade name: Endo). The listing of the drug indicates that China is at the forefront of the world in the research and development of anti-tumor drugs for vascular inhibitors; In May 2008, Yantai Rongchang Bioengineering Co., Ltd. was established in cooperation with the team of doctors studying in the United States, mainly engaged in the research and development of a new immunosuppressive genetic engineering drug "Taiai". After the project is completed, it will provide new treatment methods for patients with autoimmune diseases and B-lymphocyte tumors, and fill the blank of targeted drugs for such diseases. After the product is put on the market and forms an industrial scale, it has extremely high development and application value and broad market prospects. Adhering to the concept of "always challenging new possibilities" and highlighting the core values of "people-oriented, customer-oriented, performance-oriented, adaptable and learning-oriented organization", the company has made scientific decisions, made pioneering efforts, comprehensively enhanced its comprehensive strength and fully fulfilled its social responsibilities, and has received cordial care and strong support from party committees and governments at all levels. General Secretary Hu Jintao, Chairman Wu Bangguo and other central leaders visited the company successively to give policy guidance and financial support. It has effectively promoted the company's development, the company's strength and core competitiveness have been continuously enhanced, and the economic benefits have been improved year by year. It has been awarded the titles of "Excellent Private Sci-tech Enterprise in Shandong Province", "High-tech Enterprise in Shandong Province", "Certified Enterprise Technology Center in Shandong Province", "Modern Sci-tech Demonstration Enterprise of Traditional Chinese Medicine in Shandong Province", "Top 100 Enterprises of Yantai National Tax and National Tax Billions in 2006" with remarkable achievements.